Pharmaceutical Information Exchange Act
Bill journey · stage 1 of 5
Just introduced
What it doesSummary introduced in house (Apr 6, 2017)
Pharmaceutical Information Exchange Act
This bill amends the Federal Food, Drug, and Cosmetic Act to allow information about a new investigational medication or the investigational use of a medication approved by the Food and Drug Administration to be provided to health care entities if the information is based on reliable scientific evidence.
What just happenedJan 17, 2018
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 .
Who’s behind it
- Introduced in HouseApr 6, 2017
- Jan 17, 2018Committee
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 .
Health Subcommittee - Jan 17, 2018Committee
Subcommittee Consideration and Mark-up Session Held.
Health Subcommittee - Apr 7, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 6, 2017IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Apr 6, 2017IntroReferralIntro-H
Introduced in House
- Apr 6, 2017IntroReferral1000
Introduced in House